Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Feasibility of the Molecular Pathology Model of Patients With Glioma Via Retrospective Research

NCT04924127 is registered in ClinicalTrials.gov with Jinsong Wu as lead sponsor.

NCT NCT04924127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04924127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Feasibility of the Molecular Pathology Model of Patients With Glioma Via Retrospective Research
Lead sponsor
Jinsong Wu
Phase
Observational
Overall status
Completed
Start date
December 5, 2019
Completion date
December 20, 2021
Enrollment
976 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma, malignant